May 6, 2026 05:56PM

Mar 24, 2026 05:55AM

Mar 4, 2026 04:03PM

Feb 4, 2026 09:52AM

Jan 8, 2026 08:11AM

Dec 21, 2025 04:00AM

Dec 9, 2025 07:01AM Xencor extends US patent term on Xtend antibodies through 2028

Nov 24, 2025 07:32AM

Nov 5, 2025 05:53PM

Oct 29, 2025 04:43AM

Oct 27, 2025 09:00AM

Oct 24, 2025 12:31PM

Oct 15, 2025 07:09AM

Oct 6, 2025 06:10AM Cantor Fitzgerald Starts Xencor, Inc. (XNCR) at Overweight

Sep 17, 2025 04:40AM

Aug 21, 2025 05:16AM

Aug 6, 2025 06:23PM

May 8, 2025 10:14AM

May 7, 2025 06:04PM

Apr 29, 2025 04:02PM

Apr 21, 2025 06:38AM William Blair Starts Xencor, Inc. (XNCR) at Outperform

Mar 26, 2025 06:55AM

Mar 13, 2025 04:02PM

Feb 28, 2025 04:38AM

Dec 2, 2024 03:43AM

Nov 7, 2024 10:19AM

Nov 6, 2024 04:02PM

Oct 10, 2024 08:09AM Xencor (XNCR) Presents Preclinical Data on XmAb942

Oct 4, 2024 08:01AM

Sep 26, 2024 06:22AM

Sep 11, 2024 06:31AM

Sep 10, 2024 04:01PM

Sep 9, 2024 03:51PM

Sep 9, 2024 02:46PM

Sep 9, 2024 02:45PM Barclays Reiterates Underweight Rating on Xencor, Inc. (XNCR), PT $22, Shares Gain ~24% Today

Sep 9, 2024 02:20PM

Sep 9, 2024 07:31AM

Aug 5, 2024 04:17PM

Jun 14, 2024 07:27AM

Jun 14, 2024 06:25AM

Jun 13, 2024 08:01AM

416,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All